Regulatory and clinical considerations for biosimilar oncology drugs

C. L. Bennett, B. Chen, M. D. Wyatt, R. M. Schulz, P. Georgantopoulos, S. Kessler, Z. P. Qureshi, Z. K. Lu, B. L. Love, V. Noxon, J. Bian, P. Ray, R. J. Ablin, W. J. Hruskesky, T. Hermanson, D. W. Raisch, L. Bobolts, M. Armitage, W. J. Hrushesky, I. C. MacdougallO. Sartor, J. O. Armitage

Research output: Contribution to journalReview articlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'Regulatory and clinical considerations for biosimilar oncology drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences